AI-driven molecular building blocks and reaction-ready compounds (heterocycles, fluorinated molecules, chiral intermediates, organometallic reagents) plus custom library synthesis for drug discovery, materials science and chemical R&D. Proprietary AI optimizes molecular design and synthetic routes to accelerate lead optimization and scalable production, with ISO-compliant quality control delivering ≥95% purity.